NASDAQ
Artiva Biotherapeutics, Inc. (ARTV) has a current ratio of 8.61x as of Monday, May 25, 2026. This represents a 0.06% increase compared to its 12-month average of 8.60x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.